Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Interstitial lung diseases
Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …
State-of-the-art evidence in the treatment of systemic sclerosis
JE Pope, CP Denton, SR Johnson… - Nature Reviews …, 2023 - nature.com
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with multi-organ
involvement, fibrosis and vasculopathy. Treatment in SSc, including early diffuse cutaneous …
involvement, fibrosis and vasculopathy. Treatment in SSc, including early diffuse cutaneous …
Treatment of systemic sclerosis–associated interstitial lung disease: evidence-based recommendations. an official american thoracic society clinical practice guideline
G Raghu, SB Montesi, RM Silver, T Hossain… - American journal of …, 2024 - atsjournals.org
Background: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …
Fibroblast activation protein–specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study
M Röhrich, D Leitz, FM Glatting… - Journal of nuclear …, 2022 - jnm.snmjournals.org
Interstitial lung diseases (ILDs) comprise over 200 parenchymal lung disorders. Among
them, fibrosing ILDs, especially idiopathic pulmonary fibrosis, are associated with a poor …
them, fibrosing ILDs, especially idiopathic pulmonary fibrosis, are associated with a poor …
Nintedanib in patients with autoimmune disease–related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial
EL Matteson, C Kelly, JHW Distler… - Arthritis & …, 2022 - Wiley Online Library
Objective To analyze the efficacy and safety of nintedanib in patients with fibrosing
autoimmune disease–related interstitial lung diseases (ILDs) with a progressive phenotype …
autoimmune disease–related interstitial lung diseases (ILDs) with a progressive phenotype …
[HTML][HTML] Lung-function trajectories in COVID-19 survivors after discharge: a two-year longitudinal cohort study
H Zhang, X Li, L Huang, X Gu, Y Wang, M Liu… - …, 2022 - thelancet.com
Background Data on the long-term trajectories of lung function are scarce in COVID-19
survivors. Methods We re-analyzed the data from a prospective longitudinal cohort follow-up …
survivors. Methods We re-analyzed the data from a prospective longitudinal cohort follow-up …
Acute exacerbation of interstitial lung disease associated with rheumatic disease
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …
Potential of photon-counting detector CT for radiation dose reduction for the assessment of interstitial lung disease in patients with systemic sclerosis
L Jungblut, A Euler, J von Spiczak… - Investigative …, 2022 - journals.lww.com
Objective The aim of this study was to determine the potential of photon-counting detector
computed tomography (PCD-CT) for radiation dose reduction compared with conventional …
computed tomography (PCD-CT) for radiation dose reduction compared with conventional …
Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis
J Schniering, M Maciukiewicz… - European …, 2022 - publications.ersnet.org
Background Radiomic features calculated from routine medical images show great potential
for personalised medicine in cancer. Patients with systemic sclerosis (SSc), a rare …
for personalised medicine in cancer. Patients with systemic sclerosis (SSc), a rare …
Biomarkers in the pathogenesis, diagnosis, and treatment of systemic sclerosis
M Muruganandam, A Ariza-Hutchinson… - Journal of …, 2023 - Taylor & Francis
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by vascular
damage, vasoinstability, and decreased perfusion with ischemia, inflammation, and …
damage, vasoinstability, and decreased perfusion with ischemia, inflammation, and …